Magnera Corp (MAGN) Investment Analysis
1. Executive Summary:
Magnera Corporation (NYSE: MAGN) represents a fundamental restructuring of the global nonwovens and specialty materials landscape, emerging on November 4, 2024, as the product of a sophisticated multi-step transaction between Berry Global Group, Inc. and Glatfelter Corporation.[1, 2, 3] The entity was formed through a Reverse Morris Trust (RMT) structure, wherein Berry Global separated its Health, Hygiene, and Specialties global nonwovens and hygiene films business (HHNF) into a standalone subsidiary, Treasure Holdco, which then merged with Glatfelter.[1, 4] This strategic alignment resulted in Berry Global shareholders receiving approximately 90% of the combined company's common stock, while legacy Glatfelter shareholders retained the remaining 10%.[1, 3] Headquartered in Charlotte, North Carolina, Magnera operates as a pure-play global leader in specialty materials, possessing a massive manufacturing footprint of 45 global facilities and a workforce of approximately 8,500 employees.[5, 6, 7]
The company generates revenue by developing and manufacturing mission-critical components for essential products across two primary segments: Consumer Solutions (53% of revenue) and Personal Care (47% of revenue).[6] For the fiscal year 2025, Magnera reported pro-forma revenues of approximately $3.2 billion and an Adjusted EBITDA of $362 million.[8, 9] Its revenue model is characterized by high volume, business-to-business (B2B) relationships with the world’s largest Consumer Packaged Goods (CPG) companies and medical suppliers.[9, 10]
Magnera’s core products are engineered materials derived from both polymer-based and fiber-based technologies.[10, 11] These include airlaid and wetlaid nonwovens, spunmelt (spunbond and meltblown) fabrics, and specialized hygiene films.[9, 10] These materials serve as the structural and functional core for products such as baby diapers, adult incontinence garments, feminine hygiene pads, premium disinfectant wipes, surgical gowns, tea bags, coffee filters, and technical building wraps.[6, 7, 10]
The primary customer types for Magnera are global Tier-1 CPG firms, private label retailers, healthcare distributors, and industrial construction conglomerates.[10, 12] End markets are notably diverse, covering Wipes (20%), Infrastructure (20%), Baby Care (19%), Home, Food & Beverage (17%), Healthcare (16%), and Adult Incontinence (8%).[6] Customers choose Magnera over competitors due to its "innovation partner" status, localized global supply chain, and the ability to provide a comprehensive suite of material solutions under one roof.[10, 12] The high level of technical integration—where approximately 50% of sales to top-ten customers involve proprietary, co-developed technology—creates a formidable competitive barrier and ensures high customer retention.[10]
2. Business Drivers & Strategic Overview:
Magnera is currently defined by its transition from a legacy manufacturing model to a high-margin, innovation-driven specialty materials platform. The strategic overview focuses on the "Stabilize, Optimize, and Grow" roadmap, which aims to integrate the two massive predecessor businesses while simultaneously deleveraging the balance sheet.[6]
Product and Service Detail
Magnera’s product portfolio is built upon five foundational manufacturing platforms, each catering to specific technical requirements:
- Airlaid Technology: This process utilizes air to transport and form fibers into a web, allowing for the creation of high-loft, absorbent structures. Magnera’s airlaid materials are the industry standard for the "absorbent core" in feminine care and adult incontinence products because they can handle high fluid volumes while maintaining thinness and comfort.[10, 13]
- Wetlaid Technology: Leveraging legacy Glatfelter expertise, this process is similar to papermaking but uses specialty fibers like abaca and synthetics. This produces high-porosity materials for food and beverage applications (tea bags, coffee pods) and technical applications like wallcoverings and battery separators.[1, 10, 14]
- Spunmelt (Spunbond/Meltblown): These are polymer-based nonwovens. Spunbond layers provide tensile strength and durability, while meltblown layers act as microscopic filters. These are essential for surgical masks, gowns, and the outer layers of diapers (backsheets).[15, 16]
- Spunlace (Hydroentangling): High-pressure water jets are used to mechanically entangle fibers. This technology creates the softness and strength required for premium wipes under the Sontara brand.[10, 15]
- Films and Laminates: Magnera produces breathable films that serve as fluid barriers in hygiene products, ensuring that moisture stays trapped inside the absorbent core while allowing air to circulate, which is critical for skin health.[6, 10]
Moat Analysis
Magnera possesses a multifaceted economic moat driven by technological complexity and operational integration:
- Switching Costs: This is Magnera’s most powerful moat component. The company is often deeply embedded in the customer’s product development cycle. For a CPG brand to switch suppliers, it would require a complete re-engineering of the diaper or wipe production line, new regulatory validations, and potential loss of product performance consistency.[10, 17] The 15-year average tenure with top customers is a direct result of these costs.[10]
- Intellectual Property (IP): Magnera holds an extensive portfolio of proprietary technologies. A primary example is the newly launched PFAS-free liquid barrier solution for healthcare textiles, which recently received an INDEX™26 Award nomination.[18, 19] As global regulations restrict "forever chemicals," Magnera’s proprietary, compliant technology becomes a mandatory choice for customers.[13, 18]
- Scale and Distribution: Operating 45 facilities worldwide provides Magnera with a "localized global" advantage.[6, 7] Large customers prefer Magnera because they can source identical materials in multiple regions, reducing logistics costs and cross-border supply chain risks.[10, 12]
- Brand and Heritage: While the Magnera name is new, its constituent parts bring over 160 years of history. Brands like TYPAR (construction) and Sontara (wipes) are widely recognized for quality and reliability in their respective industries.[7, 15, 18]
TAM / Market Opportunity Analysis
The global nonwovens market is a $67 billion industry that is expected to grow steadily over the next decade.[20, 21]
| Market Metric |
Value |
Source |
| Global Nonwovens Consumption (2025) |
16.1 million tonnes |
[20] |
| Global Market Value (2025) |
$67.2 Billion |
[21] |
| Projected Value by 2030 |
$90.8 Billion |
[20] |
| Market CAGR (2025-2030) |
6.2% |
[20, 21] |
Key growth drivers within this TAM include the aging population in developed nations (driving 8.6% CAGR in adult incontinence packaging), the expansion of the middle class in Asia-Pacific (the largest and fastest-growing region), and increasing hygiene awareness in developing markets.[13, 16, 22] Magnera is positioned to capture a significant portion of this growth by focusing on the "Disposable" segment, which accounts for over 60% of the total nonwovens surface area consumption.[21]
Competitive Landscape
The industry is historically fragmented, but the formation of Magnera created one of the few truly global, full-suite players.[10, 23] Key competitors include:
- Ahlstrom (Finland): Focuses on high-performance materials for filtration and industrial applications. Magnera competes with them primarily in the "Consumer Solutions" and filtration segments.[1, 15]
- Fitesa (Brazil): A major competitor in the hygiene sector, particularly in the Americas. Fitesa has been gaining ground in low-cost spunbond applications.[1, 15]
- Freudenberg (Germany): A highly diversified industrial giant with a strong nonwovens arm. They focus more on durable industrial nonwovens rather than the high-volume disposable segments where Magnera leads.[1, 15]
- Mativ and PFNonwovens: These are smaller, more regional players that Magnera is effectively distancing through its global scale and multi-platform (polymer + fiber) offering.[1, 10]
Magnera appears to be holding ground in North America and Europe while strategically rationalizing its footprint in underperforming regions.[12, 24] The closure of the Pilar, Argentina facility in 2025 as part of "Project CORE" illustrates a shift away from low-margin commodity competition in favor of high-margin innovation.[7, 25, 26]
3. Financial Performance & Valuation:
Magnera’s financial profile as of early 2026 is that of a "distressed asset transitioning to a growth leader".[9] The market’s current skepticism is reflected in a historically low valuation, which provides the foundation for the deep-value thesis.
Recent Historical Performance (Fiscal 2025 - Q1 2026)
In fiscal 2025, the company’s first year of combined operations, Magnera achieved $3.2 billion in revenue and $362 million in Adjusted EBITDA.[8] A critical achievement was the generation of $126 million in free cash flow (FCF), which management used to initiate its aggressive deleveraging program.[6, 8]
The Q1 2026 results (ended December 27, 2025) showed a complex but improving picture:
| Financial Metric |
Q1 2026 (Actual) |
Year-over-Year Change |
| Net Sales |
$792 Million |
+13% (Merger-driven) [27] |
| Adjusted EBITDA |
$93 Million |
+11% [28] |
| GAAP Operating Income |
$14 Million |
Swung from -$22M loss [27] |
| GAAP Net Loss |
-$34 Million |
Narrowed from -$60M loss [27] |
| Organic Volume |
-1% (Consolidated) |
Driven by Europe/LATAM softness [12, 27] |
| Free Cash Flow |
-$13 Million |
Seasonally weak / integration costs [28] |
The $34 million net loss was primarily the result of $40 million in interest expense and $22 million in transaction/integration costs.[27] Without these non-operating or temporary items, the business would be significantly closer to GAAP profitability.
Valuation and Key Financial Drivers
As of April 2, 2026, Magnera trades at approximately $9.00 - $9.50 per share.[5, 29]
| Valuation Metric |
MAGN Current |
Peer/Sector Average |
| Market Capitalization |
~$323M - $338M |
N/A [30, 31] |
| Enterprise Value (EV) |
~$2.25B |
N/A [9] |
| Price-to-Sales (LTM) |
0.10x |
~1.2x [31, 32] |
| Price-to-Book (P/B) |
0.30x |
~1.3x - 1.6x [31, 32] |
| EV/EBITDA (Forward) |
~5.6x |
7.4x - 8.9x [33, 34, 35] |
Important Financial Drivers for Valuation:
- Deleveraging ($100M/Year Target): Magnera carries ~$1.9 billion in net debt, resulting in a leverage ratio of ~3.9x.[24, 28] Management’s commitment to pay down ~$100 million of debt annually from FCF is the single most important factor for equity appreciation.[12] As the debt decreases, the equity portion of the fixed Enterprise Value expands.
- Synergy Realization ($55M): The company expects to realize $55 million in cost synergies by the end of Year 3 (late 2027).[10, 24] These synergies, derived from procurement and operational efficiencies, are expected to expand EBITDA margins from the current ~11% to the mid-to-high teens.[24, 36]
- Project CORE Savings ($20M): This specific initiative aims to deliver $20 million in annual cost savings starting in fiscal 2026 through the rationalization of 5% of global capacity.[24]
- Interest Rate Sensitivity: The ~$135 million annual interest expense is the primary anchor on GAAP earnings.[6, 37] A successful deleveraging to 3.0x net debt/EBITDA would likely lead to a credit upgrade, allowing for refinancing at lower rates.[24]
- Innovation Margin Profile: Management states that margins on new products (like the PFAS-free barrier) are "well above our average of 11%," often reaching the mid-teens or over 20%.[12, 36] A shift in product mix toward these innovations will drive incremental profitability even if volume growth remains modest.
4. Risk Assessment & Macroeconomic Considerations:
Magnera’s path to a higher valuation is fraught with both internal execution hurdles and external economic headwinds.
Company-Specific Execution Risks
- Integration Complexity: The merger of HHNF and Glatfelter involves reconciling different ERP systems, corporate cultures, and logistical networks. Any disruption during this 12-month Transition Services Agreement (TSA) phase could lead to customer service failures or delayed synergy capture.[2, 23]
- Project CORE Restructuring: Closing facilities like the one in Pilar, Argentina, involves severance costs and potential supply chain disruptions. If Magnera cannot seamlessly transfer that production to other facilities, it risks losing market share in South America.[25, 26]
- Personnel Retention: The merger creates uncertainty for middle management and R&D talent. The loss of key material scientists would significantly damage Magnera’s competitive advantage as an "innovation partner".[23]
Competitive Risks
- Price Competition in Commodity Segments: While Magnera excels in specialty materials, a significant portion of its volume is in standard diaper components. Intense price pressure from low-cost Asian manufacturers, who benefit from lower energy and labor costs, could compress margins in the "Americas" and "Rest of World" segments.[13, 24]
- Rival Innovation: Competitors like Ahlstrom and Fitesa are not standing still. If a rival develops a superior bio-based or recycled substrate at a lower price point, Magnera’s 50% proprietary sales moat could be eroded.[13, 38]
Customer Concentration and Demand Risks
- CPG Leverage: Magnera’s top ten customers represent 40% of sales.[10] These massive companies (P&G, Kimberly-Clark) have significant bargaining power and can demand price concessions, particularly if raw material prices fall.[23, 28]
- Private Label Shifts: While Magnera serves both brands and private labels, a sudden shift in consumer preference toward lower-cost private labels could impact Magnera’s mix if it doesn't have an equal footprint in both.[12, 39]
Regulatory and Legal Risks
- PFAS Liabilities: Although Magnera is leading the PFAS-free transition, it may still face legacy legal liabilities related to past chemical usage at its 45 manufacturing sites.[13, 18]
- Plastic/Wipe Legislation: The UK's ban on plastic-containing wet wipes and the U.S. WIPPES Act (labeling requirements) could suppress volume for traditional polypropylene-based wipes, forcing Magnera to accelerate its transition to more expensive, capital-intensive biodegradable alternatives.[13]
Balance Sheet and Capital Allocation Risks
- Debt Servicing: At ~3.9x leverage, Magnera has very little margin for error. A significant earnings miss would make debt servicing difficult and could trigger restrictive covenants.[23, 24]
- High Interest Rate Environment: Magnera's ~$1.9B debt makes it highly sensitive to central bank policies. If rates remain higher for longer, the cost of refinancing will stay prohibitive, delaying the return to GAAP net profitability.[23]
Macroeconomic Sensitivities
- Raw Material Volatility: Magnera is exposed to the prices of polypropylene resin and wood pulp. While pass-through mechanisms exist for ~50-60% of contracts, there is often a 3-6 month "lag" that can hurt margins when prices rise rapidly or reduce reported revenue when prices fall.[27, 28]
- Regional Economic Softness: Europe’s sluggish consumer environment and South America's hyper-competitive import market are currently suppressing organic volume growth.[12, 24]
Risk Distinction Matrix
| Category |
High-Impact Failure |
Early Warning Sign |
Long-Term Thesis Damage |
| Operational |
Failure to hit $55M synergy target |
Quarterly EBITDA margin dropping below 10% |
Structural inability to compete on cost with regional players. |
| Financial |
Debt default or covenant breach |
FCF turning consistently negative for 2+ quarters |
Dilutive equity raise to pay down debt, wiping out current shareholders. |
| Market |
Loss of a Top-3 CPG customer |
Net Sales decline >10% excluding FX and price pass-through |
Loss of "innovation partner" status; commoditization of the portfolio. |
5. 5-Year Scenario Analysis:
The following scenarios are based on Magnera’s starting point of $3.2B revenue, 36M shares, and $1.9B net debt.[4, 8, 28, 33]
Base Case (Probability: 55%)
The Base Case assumes Magnera successfully navigates the "Optimize" phase. The company achieves its $55M synergy target and $20M Project CORE savings. Organic volume recovers to a steady 2.5%, and the company successfully rolls out its PFAS-free medical line.
- Fundamentals: Revenue grows at a 3.5% CAGR as the company selectively exits low-margin volume.
- Assumptions: EBITDA margins expand to 13.0% by Year 5. FCF remains strong, allowing for $500M in cumulative debt reduction.
- Valuation: The market recognizes the deleveraged business, assigning a 7.5x EV/EBITDA multiple (the historical low-end for materials).[34]
- Year 5 Math:
- Revenue: $3.80 Billion.
- EBITDA: $494 Million.
- Net Debt: $1.4 Billion.
- EV: $3.71 Billion ($494M * 7.5x).
- Equity Value: $2.31 Billion ($3.71B - $1.4B).
- Implied Share Price: ~$64.00.
High Case (Probability: 20%)
The High Case assumes Magnera becomes the global "ESG Material Leader." Rapid regulatory shifts in the EU and US force all major CPGs to switch to Magnera’s proprietary, sustainable materials, giving the company significant pricing power.
- Fundamentals: Revenue grows at a 5.5% CAGR, in line with the broader nonwoven market’s growth potential.[20]
- Assumptions: EBITDA margins reach 15.0% due to the high-margin innovation mix. Debt is reduced by $700M due to explosive FCF.
- Valuation: The market re-rates Magnera as a "Specialty Chemical" leader with a 9.5x multiple.[35]
- Year 5 Math:
- Revenue: $4.18 Billion.
- EBITDA: $627 Million.
- Net Debt: $1.2 Billion.
- EV: $5.96 Billion ($627M * 9.5x).
- Equity Value: $4.76 Billion.
- Implied Share Price: ~$132.00.
Low Case (Probability: 25%)
The Low Case assumes a "Stagnant Deleveraging." Integration costs run over, and synergies are only 50% realized. Europe enters a prolonged recession, and South American imports become even more aggressive.
- Fundamentals: Revenue remains flat at $3.2B as market share losses offset inflation.
- Assumptions: EBITDA margins stay stuck at 11.0%. High interest rates prevent significant debt reduction ($100M total over 5 years).
- Valuation: The market keeps Magnera in the "penalty box" with a distressed multiple of 5.5x.
- Year 5 Math:
- Revenue: $3.20 Billion.
- EBITDA: $352 Million.
- Net Debt: $1.8 Billion.
- EV: $1.94 Billion ($352M * 5.5x).
- Equity Value: $140 Million.
- Implied Share Price: ~$3.90.
Scenario Representation Table
| Scenario |
Year 5 Revenue |
EBITDA Assumption |
Exit Multiple |
Implied Share Price |
5-Year Total Return |
Probability |
| High Case |
$4.18B |
15.0% |
9.5x |
$132.22 |
~1,290% |
20% |
| Base Case |
$3.80B |
13.0% |
7.5x |
$64.17 |
~575% |
55% |
| Low Case |
$3.20B |
11.0% |
5.5x |
$3.89 |
-59% |
25% |
| Weighted |
$3.73B |
12.9% |
7.4x |
$62.71 |
~560% |
100% |
The probability-weighted target of $62.71 underscores the asymmetric risk-reward profile, where successful deleveraging creates exponential returns for equity holders.
TRANSFORMATION THROUGH DELEVERAGING
6. Qualitative Scorecard:
- Management Alignment (8/10): CEO Curt Begle brings deep domain expertise from Berry’s HH&S division.[11] The board includes a mix of legacy Berry and Glatfelter directors, and shareholders have overwhelmingly approved the "Say-on-Pay" incentive structure, which is tied to synergy and debt-reduction targets.[40, 41]
- Revenue Quality (7/10): The products are non-discretionary essentials.[12] However, the 1% organic volume decline in the most recent quarter and the price-pass-through volatility suggest that top-line quality is currently obscured by macro factors.[27, 28]
- Market Position (9/10): Magnera is a "Titan" in the nonwovens space. In specific niches like airlaid and specialized films, it is the primary partner for the world’s largest brands.[6, 10]
- Growth Outlook (6/10): While the TAM is growing at 6%, Magnera is currently in a "pruning" phase. Volume growth is expected to remain "flattish" in 2026 as the company focuses on "value over volume".[12, 36]
- Financial Health (3/10): With 3.9x leverage and persistent GAAP losses due to interest expense, the balance sheet is Magnera’s primary vulnerability.[24, 28]
- Business Viability (9/10): The 160-year track record and the fundamental human need for the products (hygiene, medical, filtration) ensure long-term survival.[7, 18]
- Capital Allocation (8/10): Management has been remarkably disciplined, making $27M in debt payments in a single quarter despite seasonal headwinds.[12, 27]
- Analyst Sentiment (5/10): Consensus is "Neutral/Reduce".[32, 42] Wells Fargo’s recent downgrade to "Equal Weight" and a $12 target highlights the market’s "wait-and-see" approach.[43]
- Profitability (4/10): While Adjusted EBITDA is healthy, GAAP profitability is elusive until the interest burden is reduced.[27, 28]
- Track Record (5/10): As a new combined entity, Magnera has yet to prove it can consistently generate organic volume growth outside of the merger’s umbrella.[23]
BLENDED SCORE: 6.4 / 10
DEBT REMAINS DOMINANT
7. Conclusion & Investment Thesis:
The investment thesis for Magnera Corporation is defined by an extreme valuation disconnect between its equity market capitalization (~$330M) and the strategic value of its global asset base (~$2.2B Enterprise Value).[9, 31] Magnera is currently being valued by the market as a troubled commodity manufacturer, yet its fundamentals suggest a dominant specialty materials leader.
Three primary catalysts support a significant re-rating over the next 12-24 months:
1. Systematic Deleveraging: Every $100M of debt paid down from free cash flow translates directly to equity value, assuming the Enterprise Value remains stable. At a ~0.1x P/S ratio, the equity is essentially a high-delta option on the business's solvency.[12, 31]
2. PFAS and Sustainability Inflection: Magnera’s lead in PFAS-free and plastic-free materials positions it as a beneficiary of tightening environmental regulations. This innovation-led growth is higher-margin and stickier than the legacy portfolio.[18, 19]
3. Credit Profile Improvement: As leverage moves from 3.9x toward the 3.0x target, Magnera becomes a candidate for debt refinancing. Reducing the interest burden from its current ~$135M annual rate would immediately unlock GAAP profitability and likely trigger a massive rally in the share price.[24, 37]
While risks regarding European softness and integration execution are valid, the current price—trading at 0.30x book value—suggests these risks are already priced in. For patient investors, Magnera offers a rare opportunity to own a global industrial leader at a fraction of its replacement cost.
DEEP VALUE RECOVERY
8. Technical Analysis, Price Action & Short-Term Outlook:
Magnera (MAGN) is currently in a strong bearish phase, trading at ~$9.48, well below its 200-day moving average of ~$12.30-$13.59.[44, 45] The Relative Strength Index (RSI) is in the oversold range of 20 to 47, suggesting the recent selling may be overextended.[45, 46] Short-term sentiment was dampened by Wells Fargo's target cut to $12 in March 2026, though the stock has shown it can pop +5% or more on positive earnings surprises.[12, 43, 47] The outlook remains range-bound until the Q2 2026 earnings report on May 13, 2026, which will be the next major fundamental test.[47, 48]
OVERSOLD INTEGRATION PLAY
- Form 10-K for Magnera Corp filed 11/25/2025, https://ir.magnera.com/static-files/a9836b57-5964-4144-87d4-e19ea23f385c
- Magnera Corporation - SEC.gov, https://www.sec.gov/Archives/edgar/data/41719/000110465924114009/tm2427380d4_8k.htm
- tm2412884-10_s4 - none - 69.5340954s - SEC.gov, https://www.sec.gov/Archives/edgar/data/2021031/000110465924092250/tm2412884d9_ex99-1.htm
- www.sec.gov, https://www.sec.gov/Archives/edgar/data/41719/000114036126001150/ny20057004x1_def14a.htm
- Investor Relations - Magnera, https://ir.magnera.com/investor-relations/
- Fourth Quarter and Full Year 2025 Earnings Presentation - Investor ..., https://ir.magnera.com/static-files/3efdbd8b-fa3b-41aa-af09-bb837b08541d
- Magnera Announces Strategic Exit from Argentina as Part of Project CORE Transformation, https://ir.magnera.com/news-releases/news-release-details/magnera-announces-strategic-exit-argentina-part-project-core/
- 2025 Annual Report - SEC.gov, https://www.sec.gov/Archives/edgar/data/41719/000114036126001152/ny20057004x3_ars.pdf
- Magnera Corp. Stock Price: Quote, Forecast, Splits & News (MAGN) - Perplexity, https://www.perplexity.ai/finance/MAGN
- 99.2 - SEC.gov, https://www.sec.gov/Archives/edgar/data/41719/000110465924106446/tm2425704d1_ex99-2.htm
- Berry Global and Glatfelter Announce Tax-Free Spin-Off Plan - Magnera, https://magnera.com/news/berry-global-and-glatfelter-announce-plans-for-tax-free-spin-off/
- Earnings call transcript: Magnera Q1 2026 earnings beat forecasts, stock rises, https://www.investing.com/news/transcripts/earnings-call-transcript-magnera-q1-2026-earnings-beat-forecasts-stock-rises-93CH-4488413
- Nonwoven Fabrics Market Report 2025-2030 [300 Pages & 350 Tables], https://www.marketsandmarkets.com/Market-Reports/non-woven-fabrics-market-101727296.html
- Form 10-K for Glatfelter Corp filed 02/28/2024, https://ir.magnera.com/static-files/32daf09d-b43e-4f3a-9c60-0a1f4b32fbdf
- Berry Global Inc. (US) and Freudenberg Group (Germany) are Leading Players in the Nonwoven Fabrics Market - MarketsandMarkets, https://www.marketsandmarkets.com/ResearchInsight/non-woven-fabrics-market.asp
- Non-woven Packaging Market Size, Trends, Share & Research Report 2031, https://www.mordorintelligence.com/industry-reports/non-woven-packaging-market
- graphic - SEC.gov, https://www.sec.gov/Archives/edgar/data/41719/000110465924096956/tm2423340d1_425.htm
- Magnera's Next-Generation Liquid Barrier Solution Nominated for INDEX™26 Award, https://magnera.com/news/magneras-next-generation-liquid-barrier-solution-nominated-for-index26-award/
- Magnera Introduce New Healthcare Safety & Sustainability Solution, https://magnera.com/news/magnera-introduces-innovative-solution-for-healthcare-and-beyond-focusing-on-safety-and-sustainability/
- The Future Of Global Nonwovens To 2030 - Smithers, https://www.smithers.com/services/market-reports/nonwovens/the-future-of-global-nonwovens-to-2030
- Smithers Report Tracks the Future of Global Nonwovens to 2030, https://www.nonwovens-industry.com/smithers-report-tracks-the-future-of-global-nonwovens-to-2030/
- Nonwoven Packaging Market | Global Market Analysis Report - 2035, https://www.futuremarketinsights.com/reports/nonwoven-packaging-market
- Magnera Corp Investment Analysis (NYSE: MAGN) : r/Burryology - Reddit, https://www.reddit.com/r/Burryology/comments/1iqd7uo/magnera_corp_investment_analysis_nyse_magn/
- MAGN Q3-2025 Earnings Call - Alpha Spread, https://www.alphaspread.com/security/nyse/magn/investor-relations/earnings-call/q3-2025
- Magnera Announces Operational Transition and Facility Closure as Part of Project CORE, https://www.quiverquant.com/news/Magnera+Announces+Operational+Transition+and+Facility+Closure+as+Part+of+Project+CORE
- Magnera to exit Argentina as part of restructuring plan - Nonwovens News, https://www.nonwovensnews.com/manufacturing-news/17386-magnera-to-exit-argentina-as-part-of-restructuring-plan
- Magnera Reports First Quarter Financial Results and Outlook 2026, https://magnera.com/news/magnera-reports-first-quarter-results/
- Magnera Reports First Quarter Results - Stock Titan, https://www.stocktitan.net/news/MAGN/magnera-reports-first-quarter-l2wrlg6llrk0.html
- Stock Quote & Chart - Investor Relations - Magnera, https://ir.magnera.com/stock-information/stock-quote-chart/
- Magnera Corporation: MAGN Stock Price Quote & News - Robinhood, https://robinhood.com/us/en/stocks/MAGN/
- Magnera Corp Stock Price Today | NYSE: MAGN Live - Investing.com, https://www.investing.com/equities/glatfelter
- Magnera (MAGN) Stock Price, News & Analysis - MarketBeat, https://www.marketbeat.com/stocks/NYSE/MAGN/
- MAGN Stock Price (+0.32) | Stock Quote, Chart & News for Magnera on Fox Business, https://www.foxbusiness.com/quote?stockTicker=MAGN
- Current M&A Multiples Across Sectors: 2025-2026 Reference | Valuation, https://ibinterviewquestions.com/guides/valuation-investment-banking/current-ma-multiples-across-sectors-2025-2026
- EBITDA Multiples Across Industries (2026) - Eqvista, https://eqvista.com/ebitda-multiples-by-industry/
- Magnera targets 9% EBITDA growth for 2026 as innovation and cost initiatives drive portfolio shift (NYSE:MAGN) | Seeking Alpha, https://seekingalpha.com/news/4548117-magnera-targets-9-percent-ebitda-growth-for-2026-as-innovation-and-cost-initiatives-drive
- MAGN.US (Magnera Corp placeholder) | Historical Prices and Fundamental Data API, https://eodhd.com/financial-summary/MAGN.US
- Nonwoven Fabrics Market worth $72.21 billion by 2030, at a CAGR of 5.7%, says MarketsandMarkets - GlobeNewswire, https://www.globenewswire.com/news-release/2025/08/06/3127994/0/en/Nonwoven-Fabrics-Market-worth-72-21-billion-by-2030-at-a-CAGR-of-5-7-says-MarketsandMarkets.html
- Magnera Corporation (MAGN) Q1 2026 Earnings Call Transcript | Seeking Alpha, https://seekingalpha.com/article/4866713-magnera-corporation-magn-q1-2026-earnings-call-transcript
- Magnera (NYSE: MAGN) investors approve board slate, auditor and pay - Stock Titan, https://www.stocktitan.net/sec-filings/MAGN/8-k-magnera-corp-reports-material-event-47d7b2cc72fc.html
- Magnera Corp shareholders elect board and approve auditor at annual meeting, https://uk.investing.com/news/sec-filings/magnera-corp-shareholders-elect-board-and-approve-auditor-at-annual-meeting-93CH-4555884
- Magnera (MAGN) Stock Forecast and Price Target 2026 - MarketBeat, https://www.marketbeat.com/stocks/NYSE/MAGN/forecast/
- Wells Fargo Downgrades Magnera(MAGN.US) to Hold Rating, Cuts Target Price to $12, https://news.futunn.com/en/post/70376463/wells-fargo-downgrades-magnera-magnus-to-hold-rating-cuts-target
- MAGN Technical Analysis for Magnera Corporation Stock - Barchart.com, https://www.barchart.com/stocks/quotes/MAGN/technical-analysis
- MAGN Technical Analysis, RSI and Moving Averages - Investing.com, https://www.investing.com/equities/glatfelter-technical
- Magnera (MAGN) Statistics & Valuation - Stock Analysis, https://stockanalysis.com/stocks/magn/statistics/
- Magnera (MAGN) Earnings Dates, Call Summary & Reports - TipRanks.com, https://www.tipranks.com/stocks/magn/earnings
- Magnera (MAGN) Earnings Date & Report - Investing.com, https://www.investing.com/equities/glatfelter-earnings